| Role of lncRNAs in ovarian cancer: defining new biomarkers for therapeutic purposes MK Tripathi, K Doxtater, F Keramatnia, C Zacheaus, MM Yallapu, M Jaggi, ... Drug Discovery Today 23 (9), 1635-1643, 2018 | 99 | 2018 |
| Z probe, an efficient tool for characterizing long non-coding RNA in FFPE tissues MK Tripathi, C Zacheaus, K Doxtater, F Keramatnia, C Gao, MM Yallapu, ... Non-coding RNA 4 (3), 20, 2018 | 11 | 2018 |
| WNT inhibitor ICG-001 prevents visceral metastatic triple negative breast cancer in a chemo-resistant patient derived xenograft-PDX-model I Fatima, IE Ayachi, C Zacheaus, JK Gray, R Krutilina, TN Seagroves, ... Cancer Research 77 (13_Supplement), 1233-1233, 2017 | 1 | 2017 |
| Stress regulated role of lncRNA Malat1 in colorectal cancer progression and metastasis K Doxtater, C Zacheaus, R Sekhri, UK Mishra, ZE Stiles, N Mishra, ... Cancer Research 80 (16_Supplement), 3142-3142, 2020 | | 2020 |
| MUC13 interacts with SOX2 leading to cell stemness and Anoikis resistance in colorectal cancer K Doxtater, C Zacheaus, F Keramatnia, M Chaib, M Triparthi, S Chauhan Cancer Research 79 (13_Supplement), 2647-2647, 2019 | | 2019 |
| MUC13 is a novel molecular signature, for early detection and metastatic colorectal cancer MK Tripathi, C Zacheaus, K Doxtater, Z Stiles, F Keramatnia, N Zafar, ... Cancer Research 78 (13_Supplement), 5178-5178, 2018 | | 2018 |
